Cargando…

Milan Criteria and UCSF Criteria: A Preliminary Comparative Study of Liver Transplantation Outcomes in the United States

The application of orthotopic liver transplantation (OLT) for patients with hepatocellular cancer (HCC) necessitates highly selective criteria to maximize survival and to optimize allocation of a scarce resource. The objective of this study was to compare the outcomes of OLT for HCC in patients tran...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, Supriya S., Arrington, Amanda K., McKenzie, Shaun, Mailey, Brian, Ding, Michelle, Lee, Wendy, Artinyan, Avo, Nissen, Nicholas, Colquhoun, Steven D., Kim, Joseph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432361/ https://www.ncbi.nlm.nih.gov/pubmed/22957260 http://dx.doi.org/10.1155/2012/253517

Ejemplares similares

Expansion of Liver Transplantation Criteria for Hepatocellular Carcinoma from Milan to UCSF in Australia and New Zealand and Justification for Metroticket 2.0
por: Barreto, Savio G., et al.
Publicado: (2022)

Liver Transplantation Beyond Milan Criteria
por: Lingiah, Vivek A, et al.
Publicado: (2020)

Salvage Liver Transplantation for Recurrent Hepatocellular Carcinoma within UCSF Criteria after Liver Resection
por: Liu, Fei, et al.
Publicado: (2012)

Liver transplantation for hepatocellular carcinoma beyond the Milan criteria
por: Xu, Xiao, et al.
Publicado: (2016)

Expansion of the hepatocellular carcinoma Milan criteria in liver transplantation: Future directions
por: Pavel, Mihai-Calin, et al.
Publicado: (2018)

Milan-out Criteria and Worse Intention-to-Treat Outcome Postliver Transplantation
por: Herreras, Julia, et al.
Publicado: (2019)

Expansion of the Milan criteria without any sacrifice: combination of the Hangzhou criteria with the pre-transplant platelet-to-lymphocyte ratio
por: Xia, Weiliang, et al.
Publicado: (2017)

Living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria: outcome of expanded criteria in tumor size
por: Liang, Hsin-Rou, et al.
Publicado: (2021)

Milan criteria in the MELD era—is it justifiable to extend the limits for orthotopic liver transplantation?
por: Morgul, Mehmet Haluk, et al.
Publicado: (2020)

Is liver transplantation superior to liver resection for hepatocellular carcinoma within Milan criteria?
por: Feng, Qingbo, et al.
Publicado: (2022)

Efficacy of sorafenib after liver transplantation in patients with primary hepatic carcinoma exceeding the Milan criteria: a preliminary study
por: Huang, Lei, et al.
Publicado: (2012)

LIVER TRANSPLANTATION FOR CARCINOMA HEPATOCELLULAR IN SÃO PAULO: 414 CASES BY THE MILAN/BRAZIL CRITERIA
por: SÁ, Gustavo Pilotto D., et al.
Publicado: (2016)

Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria: Multidisciplinary Approach to Improve Outcome
por: Kornberg, A.
Publicado: (2014)

Liver Transplantation in Patients with Hepatocellular Carcinoma beyond the Milan Criteria: A Comprehensive Review
por: Toniutto, Pierluigi, et al.
Publicado: (2021)

Efficacy of sorafenib after liver transplantation in patients with primary hepatic carcinoma exceeding the Milan criteria: a preliminary study [Corrigendum]
Publicado: (2013)

International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria
por: Degroote, Helena, et al.
Publicado: (2021)

Liver Transplantation for Hepatocellular Carcinoma: A Real-Life Comparison of Milan Criteria and AFP Model
por: Brusset, Bleuenn, et al.
Publicado: (2021)

Long‐term outcomes of resection versus transplantation for neuroendocrine liver metastases meeting the Milan criteria
por: Maspero, Marianna, et al.
Publicado: (2022)

Efficacy of sorafenib after liver transplantation in patients with primary hepatic carcinoma exceeding the Milan criteria: a preliminary study [Expression of concern]
Publicado: (2020)

Efficacy of sorafenib after liver transplantation in patients with primary hepatic carcinoma exceeding the Milan criteria: a preliminary study [Expression of concern] [Erratum]
Publicado: (2020)

Novel strategy of sirolimus plus thymalfasin and huaier granule on tumor recurrence of hepatocellular carcinoma beyond the UCSF criteria following liver transplantation: A single center experience
por: Zhou, Lin, et al.
Publicado: (2018)

Liver transplantation versus surgical resection for HCC meeting the Milan criteria: A propensity score analysis
por: Shen, Jun-Yi, et al.
Publicado: (2016)

Living Donor Liver Transplantation: The Optimal Curative Treatment for Hepatocellular Carcinoma Even Beyond Milan Criteria
por: Alim, Altan, et al.
Publicado: (2021)

Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria
por: Beumer, Berend R., et al.
Publicado: (2022)

Salvage Liver Transplantation for Recurrent Hepatocellular Carcinoma after Liver Resection: Retrospective Study of the Milan and Hangzhou Criteria
por: Hu, Zhenhua, et al.
Publicado: (2014)

Comparison of the long‐term outcomes of patients with hepatocellular carcinoma within the Milan criteria treated by ablation, resection, or transplantation
por: Zhang, Ning‐Ning, et al.
Publicado: (2022)

Efficacy and safety of lenvatinib for preventing tumor recurrence after liver transplantation in hepatocellular carcinoma beyond the Milan criteria
por: Guo, De-Zhen, et al.
Publicado: (2022)

Individualised tailored assessment of therapeutic alternatives for HCC patients within the Milan criteria
por: Zhang, Ningning, et al.
Publicado: (2020)

Nucleic acid visualization with UCSF Chimera
por: Couch, Gregory S., et al.
Publicado: (2006)

Infectious diseases management program at UCSF
Publicado: (2019)

Assessing the role of everolimus in reducing hepatocellular carcinoma recurrence after living donor liver transplantation for patients within the UCSF criteria: re-inventing the role of mammalian target of rapamycin inhibitors
por: Thorat, Ashok, et al.
Publicado: (2017)

Sorafenib for hepatocellular carcinoma patients beyond Milan criteria after orthotopic liver transplantation: a case control study
por: Teng, Chieh-Lin, et al.
Publicado: (2012)

Retraction: Salvage Liver Transplantation for Recurrent Hepatocellular Carcinoma after Liver Resection: Retrospective Study of the Milan and Hangzhou Criteria
Publicado: (2019)

Simple Risk Score for Prediction of Early Recurrence of Hepatocellular Carcinoma within the Milan Criteria after Orthotopic Liver Transplantation
por: Feng, Jiliang, et al.
Publicado: (2017)

Comparison of treatment outcome between living donor liver transplantation and sorafenib for patients with hepatocellular carcinoma beyond the Milan criteria
por: Cho, Yuri, et al.
Publicado: (2017)

Patients Benefit from Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria without Harming the Health Care System
por: Gundlach, Jan-Paul, et al.
Publicado: (2022)

Liver resection versus liver transplantation for hepatocellular carcinoma within the Milan criteria based on estimated microvascular invasion risks
por: Yang, Pinghua, et al.
Publicado: (2023)

ANXIETY DURING THE COVID-19 PANDEMIC: PRELIMINARY FINDINGS FROM THE UCSF ASPIRE STUDY
por: Morris, Jerrine R., et al.
Publicado: (2021)

Sarcopenia as a predictor of post-transplant tumor recurrence after living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria
por: Kim, Young Ri, et al.
Publicado: (2018)

Long-Term Outcomes of Percutaneous Cryoablation for Patients with Hepatocellular Carcinoma within Milan Criteria
por: Rong, Guanghua, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_p8i54d7vk7og7mff2s9li097g0